跳至主要内容
临床试验/NL-OMON52368
NL-OMON52368招募中不适用

A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study - SANO-2 study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 900 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Operable patients who are planned to undergo or who recently underwent
  • neoadjuvant chemoradiotherapy according to CROSS followed by surgical resection
  • for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma
  • of the oesophagus or oesophago-gastric junction
  • - Age >=18
  • - Written, voluntary, informed consent.

排除标准

  • - Non-FDG-avid tumour at baseline PET-CT scan
  • - Initial treatment with endoscopic resection
  • - Patients who underwent of who are planned to undergo definitive
  • chemoradiotherapy
  • - Language difficulty, dementia or altered mental status prohibiting the
  • understanding and giving of informed consent.

研究者

相似试验